|
CSNK1A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.259200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.431000E-01 |
| Normal-vs-Stage2 |
4.443400E-01 |
| Normal-vs-Stage3 |
9.721600E-01 |
| Normal-vs-Stage4 |
5.016200E-01 |
| Stage1-vs-Stage2 |
9.191400E-01 |
| Stage1-vs-Stage3 |
2.113800E-01 |
| Stage1-vs-Stage4 |
4.715900E-02 |
| Stage2-vs-Stage3 |
3.731800E-01 |
| Stage2-vs-Stage4 |
1.957350E-01 |
| Stage3-vs-Stage4 |
4.880000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.722800E-01 |
| Normal-vs-AfricanAmerican |
5.430200E-01 |
| Normal-vs-Asian |
8.821400E-01 |
| Caucasian-vs-AfricanAmerican |
8.987000E-01 |
| Caucasian-vs-Asian |
6.042200E-01 |
| AfricanAmerican-vs-Asian |
6.284400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.637800E-01 |
| Normal-vs-Female |
5.729200E-01 |
| Male-vs-Female |
7.439800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.664200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.184600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.875400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.324000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.079600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.116200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.957800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.973050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.877600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.579000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.296000E-02 |
| Classical-VS-Follicular |
1.044840E-03 |
| Classical-VS-Other |
1.611440E-01 |
| Classical-VS-Normal |
9.624300E-02 |
| Tall-VS-Follicular |
6.944000E-01 |
| Tall-VS-Other |
6.180000E-01 |
| Tall-VS-Normal |
7.424000E-01 |
| Follicular-VS-Other |
7.615200E-01 |
| Follicular-VS-Normal |
3.709800E-01 |
| Other-VS-Normal |
4.375400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.074800E-01 |
| Normal-vs-N1 |
7.939400E-01 |
| N0-vs-N1 |
8.619000E-01 |
|
|
